X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (72) 72
neurosciences (66) 66
mice (62) 62
male (51) 51
index medicus (45) 45
life sciences (43) 43
mice, inbred c57bl (35) 35
dopamine (28) 28
cocaine (26) 26
phosphorylation (26) 26
synaptic plasticity (25) 25
striatum (24) 24
brain (23) 23
nucleus-accumbens (22) 22
mice, transgenic (21) 21
neurons and cognition (21) 21
neurons (19) 19
basal ganglia (18) 18
neurons - metabolism (18) 18
neuroscience (18) 18
pharmacology & pharmacy (18) 18
reward (18) 18
extracellular signal-regulated map kinases - metabolism (17) 17
mice, knockout (16) 16
proteins (15) 15
receptors (15) 15
signal transduction - drug effects (15) 15
motor activity - drug effects (14) 14
neostriatum (14) 14
[sdv]life sciences [q-bio] (13) 13
activation (13) 13
behavior, animal - drug effects (13) 13
receptors, dopamine d1 - metabolism (13) 13
cocaine - pharmacology (12) 12
cognitive sciences (12) 12
corpus striatum - metabolism (12) 12
dopamine receptors (12) 12
gene-expression (12) 12
long-term potentiation (12) 12
memory (12) 12
multidisciplinary sciences (12) 12
phosphorylation - drug effects (12) 12
psychiatry (12) 12
rodents (12) 12
signal transduction (12) 12
addiction (11) 11
drug abuse (11) 11
extracellular signal-regulated kinase (11) 11
gene expression (11) 11
kinases (11) 11
neurons - drug effects (11) 11
rat-brain (11) 11
signal transduction - physiology (11) 11
[sdv.neu.sc]life sciences [q-bio]/neurons and cognition [q-bio.nc]/cognitive sciences (10) 10
c-fos (10) 10
corpus striatum - cytology (10) 10
corpus striatum - drug effects (10) 10
darpp-32 (10) 10
dopamine and camp-regulated phosphoprotein 32 - metabolism (10) 10
enzyme activation - drug effects (10) 10
female (10) 10
in-vivo (10) 10
striatal neurons (10) 10
behavioral sensitization (9) 9
brain - drug effects (9) 9
neurobiology (9) 9
nucleus accumbens (9) 9
place preference (9) 9
plasticity (9) 9
receptors, dopamine d2 - genetics (9) 9
receptors, dopamine d2 - metabolism (9) 9
[ sdv.neu.sc ] life sciences [q-bio]/neurons and cognition [q-bio.nc]/cognitive sciences (8) 8
analysis of variance (8) 8
article (8) 8
biochemistry & molecular biology (8) 8
brain - metabolism (8) 8
conditioned place preference (8) 8
dopamine and camp-regulated phosphoprotein 32 - genetics (8) 8
dopamine d1 receptors (8) 8
erk (8) 8
histones - metabolism (8) 8
medium spiny neurons (8) 8
nervous system (8) 8
parkinson's disease (8) 8
phenols (8) 8
rats (8) 8
receptors, dopamine d1 - genetics (8) 8
signal-regulated kinase (8) 8
amphetamine (7) 7
gene expression regulation - drug effects (7) 7
green fluorescent proteins - genetics (7) 7
hippocampus (7) 7
histone h3 (7) 7
interneurons (7) 7
messenger-rna (7) 7
mitogen-activated protein kinases - metabolism (7) 7
mouse (7) 7
neurology (7) 7
neuronal plasticity - physiology (7) 7
parkinsons-disease (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 2014, Volume 509, Issue 7501, pp. 459 - 464
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2010, Volume 107, Issue 33, pp. 14845 - 14850
The direct and indirect pathways of the basal ganglia have been proposed to oppositely regulate locomotion and differentially contribute to pathological... 
Locomotion | Receptors | Basal ganglia | Neurons | Catalepsy | Antipsychotic agents | Cocaine | Behavioral neuroscience | Genotypes | Dyskinesia | DARPP-32 | Striatopallidal | Striatonigral | Locomotor behavior | basal ganglia | DOPA-INDUCED DYSKINESIA | NEUROTRANSMISSION | MULTIDISCIPLINARY SCIENCES | COCAINE | MODEL | striatopallidal | STRIATOPALLIDAL NEURONS | locomotor behavior | MICE | striatonigral | D1 RECEPTOR | PARKINSONS-DISEASE | Immunohistochemistry | Motor Activity - physiology | Dyskinesia, Drug-Induced - physiopathology | Dopamine and cAMP-Regulated Phosphoprotein 32 - genetics | Motor Activity - drug effects | Male | Neurons - cytology | Green Fluorescent Proteins - genetics | Corpus Striatum - cytology | Corpus Striatum - metabolism | Catalepsy - physiopathology | Neurons - classification | Neuronal Plasticity - physiology | Catalepsy - chemically induced | Long-Term Potentiation - physiology | Female | Neurons - metabolism | Dyskinesia, Drug-Induced - etiology | Green Fluorescent Proteins - metabolism | Synaptic Potentials - physiology | Dopamine Uptake Inhibitors - pharmacology | Mice, Inbred C57BL | Mice, Transgenic | Levodopa - toxicity | Dopamine and cAMP-Regulated Phosphoprotein 32 - metabolism | Mice, Knockout | Cocaine - pharmacology | Animals | Dopamine and cAMP-Regulated Phosphoprotein 32 - physiology | Fluorescent Antibody Technique | Dopamine Agents - toxicity | Mice | Haloperidol - toxicity | Human locomotion | Health aspects | Motor ability | Drugs | Animal models | Neuroleptics | Parkinson's disease | Neurodegenerative diseases | Haloperidol | spiny neurons | Signal transduction | Clonal deletion | Neostriatum | DARPP-32 protein | Levodopa | Locomotor activity | Movement disorders | Biological Sciences
Journal Article
The FEBS Journal, ISSN 1742-464X, 04/2008, Volume 275, Issue 7, pp. 1392 - 1399
l‐3,4‐Dihydroxyphenylalanine (l‐dopa) remains the most effective pharmacological treatment for relief of the severe motor impairments of Parkinson’s disease.... 
extracellular signal‐regulated kinase | striatum | 6‐hydroxydopamine | immediate early genes | medium spiny neurons | cAMP‐dependent protein kinase | 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine | phosphorylation | dopamine D1 receptor | DA‐ and cAMP‐regulated phosphoprotein of 32 kDa | 6-hydroxydopamine | Immediate early genes | DA- and cAMP-regulated phosphoprotein of 32 kDa | Medium spiny neurons | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | Extracellular signal-regulated kinase | Dopamine D1 receptor | cAMP-dependent protein kinase | extracellular signal-regulated kinase | DOPA-INDUCED DYSKINESIA | STIMULATED ADENYLYL-CYCLASE | PROTEIN-KINASE | BASAL GANGLIA | BIOCHEMISTRY & MOLECULAR BIOLOGY | BEHAVIORAL SENSITIZATION | ADENOSINE-A2 RECEPTOR | SUBSTANTIA-NIGRA | NUCLEUS-ACCUMBENS | and cAMP-regulated phosphoprotein of 32 kDa | STRIATAL DOPAMINE | 6-HYDROXYDOPAMINE LESIONS | Dyskinesia, Drug-Induced - physiopathology | Levodopa - therapeutic use | Humans | Parkinson Disease - drug therapy | Parkinson Disease - physiopathology | Antiparkinson Agents - adverse effects | Antiparkinson Agents - therapeutic use | Animals | Signal Transduction - drug effects | Levodopa - adverse effects | Signal Transduction - physiology | Parkinson Disease - metabolism | Dyskinesia, Drug-Induced - metabolism | Drug Delivery Systems - adverse effects | Parkinson's disease | Dopamine receptors | Signal transduction | Neurotransmitters | Biochemistry | Pharmacology | Drug dosages | Parkinsons disease | Index Medicus
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 06/2007, Volume 27, Issue 26, pp. 6995 - 7005
Journal Article
NATURE COMMUNICATIONS, ISSN 2041-1723, 04/2019, Volume 10, Issue 1, pp. 1697 - 8
Journal Article
FRONTIERS IN BEHAVIORAL NEUROSCIENCE, ISSN 1662-5153, 03/2014, Volume 8
The fine-tuning of neuronal excitability relies on a tight control of Ca2+ homeostasis. The low voltage-activated (LVA) T-type calcium channels (Ca(v)3.1,... 
NERVOUS-SYSTEM | psychostimulants | CA2+ CHANNELS | BEHAVIORAL SENSITIZATION | COCAINE | LOW-THRESHOLD EXOCYTOSIS | NEUROSCIENCES | NUCLEUS-ACCUMBENS | drugs of abuse | anxiety | IN-VITRO | CLONING | T-type Ca2+ channels | spontaneous behavior | NEURONS | GENE FAMILY | BEHAVIORAL SCIENCES | memory and learning
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 02/2009, Volume 108, Issue 3, pp. 621 - 633
In the dopamine‐depleted striatum, extracellular signal‐regulated kinase (ERK) signaling is implicated in the development of l‐DOPA‐induced dyskinesia. To gain... 
bacterial artificial chromosome | l‐DOPA‐induced dyskinesia | mitogen‐ and stress‐activated kinase 1 | striatum | transgenic mice | Parkinson’s disease | Striatum | Bacterial artificial chromosome | Mitogen- and stress-activated kinase 1 | Parkinson's disease | L-DOPA-induced dyskinesia | Transgenic mice | mitogen- and stress-activated kinase 1 | BIOCHEMISTRY & MOLECULAR BIOLOGY | KINASE | D-1 | ABNORMAL INVOLUNTARY MOVEMENTS | SYNAPTIC PLASTICITY | NEUROSCIENCES | RAT MODEL | LEVODOPA-INDUCED DYSKINESIA | PHOSPHATASE CASCADE | FOSB EXPRESSION | l-DOPA-induced dyskinesia | RECEPTORS | PARKINSONS-DISEASE | Phosphorylation | Antiparkinson Agents - pharmacology | Sympatholytics | Male | Substantia Nigra - metabolism | Oxidopamine | Substantia Nigra - cytology | Ribosomal Protein S6 Kinases, 90-kDa - metabolism | Neurons - ultrastructure | Neostriatum - drug effects | Receptors, Dopamine D2 - drug effects | Parkinson Disease, Secondary - metabolism | Neostriatum - metabolism | Neurons - metabolism | Parkinson Disease, Secondary - chemically induced | Extracellular Signal-Regulated MAP Kinases - physiology | Neurons - drug effects | Levodopa - pharmacology | Neostriatum - cytology | Mice, Inbred C57BL | Receptors, Dopamine D1 - drug effects | Dyskinesias - physiopathology | Blotting, Western | Receptors, Dopamine D2 - genetics | Substantia Nigra - drug effects | Animals | Signal Transduction - drug effects | Fluorescent Antibody Technique | Mice | Histones - metabolism | Receptors, Dopamine D1 - genetics | Neurosciences | Phosphoproteins | Neurons | Fluorescence | Phenols | Mitogens | Dopamine receptors | Neurology | Signal transduction | Biochemistry | Rodents | Parkinsons disease | Index Medicus
Journal Article
Journal Article
Journal Article